Dr Steven Feldman joins Drs Jennifer Cather and Brad Glick to discuss how much monitoring systemic psoriasis treatments really require in modern practice.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep3-2026a10006hk. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis
https://emedicine.medscape.com/article/1943419-overview

Psoriasis: An Update on Topical and Systemic Therapies
https://pubmed.ncbi.nlm.nih.gov/40568686/

Crosstalk Between White Adipose Tissue and Skin: Unraveling Its Role in Psoriasis Pathogenesis (Review)
https://pubmed.ncbi.nlm.nih.gov/40242953/

Joint AAD-NPF Guidelines of Care for the Management and Treatment of Psoriasis With Biologics
https://pubmed.ncbi.nlm.nih.gov/30772098/

Joint American Academy of Dermatology-National Psoriasis Foundation Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologic Therapies
https://pubmed.ncbi.nlm.nih.gov/32119894/

Oral Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: A Systematic Review and Meta-analysis
https://pubmed.ncbi.nlm.nih.gov/36751339/

Janus Kinase Inhibitors for Alopecia Areata: A Review of Clinical Data
https://pubmed.ncbi.nlm.nih.gov/40433365/

Herpes Zoster
https://emedicine.medscape.com/article/1132465-overview

Clinical Testing Guidance for Tuberculosis: Interferon Gamma Release Assay
https://www.cdc.gov/tb/hcp/testing-diagnosis/interferon-gamma-release-assay.html

Utility of Repeat Latent Tuberculosis Testing With the QuantiFERON-TB Gold Test in Patients With Psoriasis Treated With Tumour Necrosis Factor-α Inhibitors at a Single U.S. Institution
https://pubmed.ncbi.nlm.nih.gov/31452192/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
https://pubmed.ncbi.nlm.nih.gov/41191940/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Drs Steven Feldman and Tina Bhutani-Jacques explore how next-generation oral therapies are closing the gap with biologics and reshaping psoriasis care.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep2-2026a10006a5. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Acitretin Revisited in the Era of Biologics https://pubmed.ncbi.nlm.nih.gov/20673152/

Apremilast in Psoriasis: Current Landscape and Perspectives https://pubmed.ncbi.nlm.nih.gov/40739686/

Deucravacitinib Versus Placebo and Apremilast in Moderate-to-Severe Plaque Psoriasis: Efficacy and Safety Results From the 52-Week, Randomized, Double-Blinded, Placebo-Controlled Phase 3 POETYK PSO-1 Trial https://pubmed.ncbi.nlm.nih.gov/35820547/

Apremilast Prescribing Information https://www.pi.amgen.com/-/media/Project/Amgen/Repository/pi-amgen-com/Otezla/otezla_pi_english.pdf

Deucravacitinib Prescribing Information https://packageinserts.bms.com/pi/pi_sotyktu.pdf

Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/39167366/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents https://pubmed.ncbi.nlm.nih.gov/41191940/

National Psoriasis Foundation https://www.psoriasis.org/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Drs Steven Feldman and Bernard Vrijens as they discuss the theory and practice of improving treatment adherence for better patient outcomes in psoriasis.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-psoriasis-s4-ep1-2026a10006a1. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Psoriasis https://emedicine.medscape.com/article/1943419-overview

The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results https://pubmed.ncbi.nlm.nih.gov/38135800/

Comparing Compliance Patterns Between Randomized Treatments https://pubmed.ncbi.nlm.nih.gov/9204220/

A Scoping Review of Studies Comparing the Medication Event Monitoring System (MEMS) With Alternative Methods for Measuring Medication Adherence https://pubmed.ncbi.nlm.nih.gov/27005306/

A New Taxonomy for Describing and Defining Adherence to Medications https://pubmed.ncbi.nlm.nih.gov/22486599/

One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic https://pubmed.ncbi.nlm.nih.gov/18467003/

Data Resource Profile: The Danish National Prescription Registry https://pubmed.ncbi.nlm.nih.gov/27789670/

Tachyphylaxis to Topical Glucocorticoids; What Is the Evidence? https://pubmed.ncbi.nlm.nih.gov/24010503/

Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents https://pubmed.ncbi.nlm.nih.gov/38258121/

10 Tips to Improve Adherence to Immunosuppressive Medication After Kidney Transplantation https://pubmed.ncbi.nlm.nih.gov/40521289/

The Health Buddies App as a Novel Tool to Improve Adherence and Knowledge in Atrial Fibrillation Patients: A Pilot Study https://pubmed.ncbi.nlm.nih.gov/28724512/

6MP Adherence in a Multiracial Cohort of Children With Acute Lymphoblastic Leukemia: A Children's Oncology Group Study https://pubmed.ncbi.nlm.nih.gov/24829202/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.